Literature DB >> 29731169

Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses.

Mohammad Mohseni Sajadi1, Amir Dashti2, Zahra Rikhtegaran Tehrani3, William D Tolbert2, Michael S Seaman4, Xin Ouyang2, Neelakshi Gohain2, Marzena Pazgier2, Dongkyoon Kim5, Guy Cavet5, Jean Yared6, Robert R Redfield2, George K Lewis2, Anthony L DeVico2.   

Abstract

Anti-HIV-1 envelope broadly neutralizing monoclonal antibodies (bNAbs) isolated from memory B cells may not fully represent HIV-1-neutralizing profiles measured in plasma. Accordingly, we characterized near-pan-neutralizing antibodies extracted directly from the plasma of two "elite neutralizers." Circulating anti-gp120 polyclonal antibodies were deconvoluted using proteomics to guide lineage analysis of bone marrow plasma cells. In both subjects, a single lineage of anti-CD4-binding site (CD4bs) antibodies explained the plasma-neutralizing activity. Importantly, members of these lineages potently neutralized 89%-100% of a multi-tier 117 pseudovirus panel, closely matching the specificity and breadth of the circulating antibodies. X-ray crystallographic analysis of one monoclonal, N49P7, suggested a unique ability to bypass the CD4bs Phe43 cavity, while reaching deep into highly conserved residues of Layer 3 of the gp120 inner domain, likely explaining its extreme potency and breadth. Further direct analyses of plasma anti-HIV-1 bNAbs should provide new insights for developing antibody-based antiviral agents and vaccines.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV-1; antibody; broadly neutralizing antibody; humoral immunity; pan-neutralization; repertoire

Mesh:

Substances:

Year:  2018        PMID: 29731169      PMCID: PMC6003858          DOI: 10.1016/j.cell.2018.03.061

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  55 in total

1.  Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response.

Authors:  Yariv Wine; Daniel R Boutz; Jason J Lavinder; Aleksandr E Miklos; Randall A Hughes; Kam Hon Hoi; Sang Taek Jung; Andrew P Horton; Ellen M Murrin; Andrew D Ellington; Edward M Marcotte; George Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

2.  Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.

Authors:  Jinghe Huang; Byong H Kang; Elise Ishida; Tongqing Zhou; Trevor Griesman; Zizhang Sheng; Fan Wu; Nicole A Doria-Rose; Baoshan Zhang; Krisha McKee; Sijy O'Dell; Gwo-Yu Chuang; Aliaksandr Druz; Ivelin S Georgiev; Chaim A Schramm; Anqi Zheng; M Gordon Joyce; Mangaiarkarasi Asokan; Amy Ransier; Sam Darko; Stephen A Migueles; Robert T Bailer; Mark K Louder; S Munir Alam; Robert Parks; Garnett Kelsoe; Tarra Von Holle; Barton F Haynes; Daniel C Douek; Vanessa Hirsch; Michael S Seaman; Lawrence Shapiro; John R Mascola; Peter D Kwong; Mark Connors
Journal:  Immunity       Date:  2016-11-15       Impact factor: 31.745

3.  Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env.

Authors:  Ivelin S Georgiev; M Gordon Joyce; Yongping Yang; Mallika Sastry; Baoshan Zhang; Ulrich Baxa; Rita E Chen; Aliaksandr Druz; Christopher R Lees; Sandeep Narpala; Arne Schön; Joseph Van Galen; Gwo-Yu Chuang; Jason Gorman; Adam Harned; Marie Pancera; Guillaume B E Stewart-Jones; Cheng Cheng; Ernesto Freire; Adrian B McDermott; John R Mascola; Peter D Kwong
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

4.  HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.

Authors:  Joseph G Jardine; Daniel W Kulp; Colin Havenar-Daughton; Anita Sarkar; Bryan Briney; Devin Sok; Fabian Sesterhenn; June Ereño-Orbea; Oleksandr Kalyuzhniy; Isaiah Deresa; Xiaozhen Hu; Skye Spencer; Meaghan Jones; Erik Georgeson; Yumiko Adachi; Michael Kubitz; Allan C deCamp; Jean-Philippe Julien; Ian A Wilson; Dennis R Burton; Shane Crotty; William R Schief
Journal:  Science       Date:  2016-03-25       Impact factor: 47.728

5.  Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.

Authors:  Xueling Wu; Zhi-Yong Yang; Yuxing Li; Carl-Magnus Hogerkorp; William R Schief; Michael S Seaman; Tongqing Zhou; Stephen D Schmidt; Lan Wu; Ling Xu; Nancy S Longo; Krisha McKee; Sijy O'Dell; Mark K Louder; Diane L Wycuff; Yu Feng; Martha Nason; Nicole Doria-Rose; Mark Connors; Peter D Kwong; Mario Roederer; Richard T Wyatt; Gary J Nabel; John R Mascola
Journal:  Science       Date:  2010-07-08       Impact factor: 47.728

6.  Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors.

Authors:  Amandeep K Dhillon; Helen Donners; Ralph Pantophlet; Welkin E Johnson; Julie M Decker; George M Shaw; Fang-Hua Lee; Douglas D Richman; Robert W Doms; Guido Vanham; Dennis R Burton
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

7.  Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions.

Authors:  Andrés Finzi; Shi-Hua Xiang; Beatriz Pacheco; Liping Wang; Jessica Haight; Aemro Kassa; Brenda Danek; Marie Pancera; Peter D Kwong; Joseph Sodroski
Journal:  Mol Cell       Date:  2010-03-12       Impact factor: 17.970

8.  Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors.

Authors:  Mohammad M Sajadi; Neil T Constantine; Dean L Mann; Manhattan Charurat; Elham Dadzan; Peter Kadlecik; Robert R Redfield
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-01       Impact factor: 3.731

9.  Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals.

Authors:  Yuxing Li; Krisha Svehla; Mark K Louder; Diane Wycuff; Sanjay Phogat; Min Tang; Stephen A Migueles; Xueling Wu; Adhuna Phogat; George M Shaw; Mark Connors; James Hoxie; John R Mascola; Richard Wyatt
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

10.  Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits.

Authors:  James E Robinson; Kathryn M Hastie; Robert W Cross; Rachael E Yenni; Deborah H Elliott; Julie A Rouelle; Chandrika B Kannadka; Ashley A Smira; Courtney E Garry; Benjamin T Bradley; Haini Yu; Jeffrey G Shaffer; Matt L Boisen; Jessica N Hartnett; Michelle A Zandonatti; Megan M Rowland; Megan L Heinrich; Luis Martínez-Sobrido; Benson Cheng; Juan C de la Torre; Kristian G Andersen; Augustine Goba; Mambu Momoh; Mohamed Fullah; Michael Gbakie; Lansana Kanneh; Veronica J Koroma; Richard Fonnie; Simbirie C Jalloh; Brima Kargbo; Mohamed A Vandi; Momoh Gbetuwa; Odia Ikponmwosa; Danny A Asogun; Peter O Okokhere; Onikepe A Follarin; John S Schieffelin; Kelly R Pitts; Joan B Geisbert; Peter C Kulakoski; Russell B Wilson; Christian T Happi; Pardis C Sabeti; Sahr M Gevao; S Humarr Khan; Donald S Grant; Thomas W Geisbert; Erica Ollmann Saphire; Luis M Branco; Robert F Garry
Journal:  Nat Commun       Date:  2016-05-10       Impact factor: 14.919

View more
  43 in total

Review 1.  Subdominance in Antibody Responses: Implications for Vaccine Development.

Authors:  Gunnar Lindahl
Journal:  Microbiol Mol Biol Rev       Date:  2020-11-25       Impact factor: 11.056

2.  Complementary Roles of Antibody Heavy and Light Chain Somatic Hypermutation in Conferring Breadth and Potency to the HIV-1-Specific CAP256-VRC26 bNAb Lineage.

Authors:  David Sacks; Kevin Wiehe; Lynn Morris; Penny L Moore
Journal:  J Virol       Date:  2022-05-05       Impact factor: 6.549

3.  HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell Receptors.

Authors:  Yu-Ru Lin; K Rachael Parks; Connor Weidle; Anika S Naidu; Arineh Khechaduri; Andrew O Riker; Brittany Takushi; Jung-Ho Chun; Andrew J Borst; David Veesler; Andrew Stuart; Parul Agrawal; Matthew Gray; Marie Pancera; Po-Ssu Huang; Leonidas Stamatatos
Journal:  Immunity       Date:  2020-10-13       Impact factor: 31.745

4.  Rational Engraftment of Quaternary-Interactive Acidic Loops for Anti-HIV-1 Antibody Improvement.

Authors:  Qingbo Liu; Peng Zhang; Huiyi Miao; Yin Lin; Young Do Kwon; Peter D Kwong; Zahra Rikhtegaran-Tehrani; Michael S Seaman; Anthony L DeVico; Mohammad M Sajadi; Paolo Lusso
Journal:  J Virol       Date:  2021-05-24       Impact factor: 5.103

5.  Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells.

Authors:  Evan D Rossignol; Anne-Sophie Dugast; Hacheming Compere; Christopher A Cottrell; Jeffrey Copps; Shu Lin; Deniz Cizmeci; Michael S Seaman; Margaret E Ackerman; Andrew B Ward; Galit Alter; Boris Julg
Journal:  Cell Rep       Date:  2021-05-25       Impact factor: 9.423

6.  Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies.

Authors:  Emilie Seydoux; Yu-Hsin Wan; Junli Feng; Abigail Wall; Safia Aljedani; Leah J Homad; Anna J MacCamy; Connor Weidle; Matthew D Gray; Lauren Brumage; Justin J Taylor; Marie Pancera; Leonidas Stamatatos; Andrew T McGuire
Journal:  Cell Rep       Date:  2021-05-04       Impact factor: 9.423

7.  Characterization of human IgM and IgG repertoires in individuals with chronic HIV-1 infection.

Authors:  Xiaolong Tian; Binbin Hong; Xiaoyi Zhu; Desheng Kong; Yumei Wen; Yanling Wu; Liying Ma; Tianlei Ying
Journal:  Virol Sin       Date:  2022-03-03       Impact factor: 6.947

8.  Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial.

Authors:  Joel V Chua; Charles Davis; Jennifer S Husson; Amy Nelson; Ilia Prado; Robin Flinko; Ka Wing J Lam; Lydiah Mutumbi; Bryan T Mayer; Dan Dong; William Fulp; Celia Mahoney; Monica Gerber; Raphael Gottardo; Bruce L Gilliam; Kelli Greene; Hongmei Gao; Nicole Yates; Guido Ferrari; Georgia Tomaras; David Montefiori; Jennifer A Schwartz; Timothy Fouts; Anthony L DeVico; George K Lewis; Robert C Gallo; Mohammad M Sajadi
Journal:  Vaccine       Date:  2021-06-04       Impact factor: 3.641

Review 9.  Recent progress in broadly neutralizing antibodies to HIV.

Authors:  Devin Sok; Dennis R Burton
Journal:  Nat Immunol       Date:  2018-10-17       Impact factor: 31.250

10.  HIV-1 gp120-CD4-Induced Antibody Complex Elicits CD4 Binding Site-Specific Antibody Response in Mice.

Authors:  Andrey Galkin; Yajing Chen; Javier Guenaga; Sijy O'Dell; Roderico Acevedo; James J Steinhardt; Yimeng Wang; Richard Wilson; Chi-I Chiang; Nicole Doria-Rose; Alexander V Grishaev; John R Mascola; Yuxing Li
Journal:  J Immunol       Date:  2020-02-17       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.